FilingIndex
← The Wire
BCAXNasdaq

Bicara Therapeutics Inc.

Pharmaceutical Preparations · DE · CIK 2023658

Bicara Therapeutics develops bifunctional therapies targeting solid tumors by delivering payloads to tumor sites

$1.43B
Market cap
$29.34
Last close
+9.2%
1D
+19.5%
5D
1.6M
Volume
Price · last 39 sessions+29.1%
May 4L $19.29 · H $29.34Jun 29
41
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Mar 25, 2026: 1 insider bought $4.8M · 4 sold $2.8M.

DateInsiderActionSharesPriceValue
Mar 25, 2026Raben DavidChief Medical OfficerSell5,500$18.95$104K
Mar 23, 2026Hyep IvanChief Financial OfficerSell9,200$18.52$170K
Mar 20, 2026Mazumdar ClaireChief Executive OfficerSell1,596$18.95$30K
Mar 19, 2026Mazumdar ClaireChief Executive OfficerSell6,905$18.78$130K
Mar 18, 2026Mazumdar ClaireChief Executive OfficerSell6,499$18.84$122K
Mar 16, 2026Cohlhepp RyanPresident and COOSell8,000$19.66$157K
Mar 16, 2026Cohlhepp RyanPresident and COOSell4,500$19.66$88K
Mar 9, 2026Mazumdar ClaireChief Executive OfficerSell36,766$19.17$705K
Mar 6, 2026Mazumdar ClaireChief Executive OfficerSell3,817$18.75$72K
Mar 5, 2026Mazumdar ClaireChief Executive OfficerSell1,786$18.74$33K
Mar 4, 2026Raben DavidChief Medical OfficerSell16,300$18.52$302K
Mar 4, 2026Hyep IvanChief Financial OfficerSell2,963$18.25$54K
Mar 4, 2026Mazumdar ClaireChief Executive OfficerSell2,631$18.73$49K
Mar 3, 2026Hyep IvanChief Financial OfficerSell13,555$18.22$247K
Mar 3, 2026Cohlhepp RyanPresident and COOSell12,892$18.16$234K
Mar 3, 2026Cohlhepp RyanPresident and COOSell4,500$18.16$82K
Mar 3, 2026Raben DavidChief Medical OfficerSell200$18.45$4K
Feb 26, 2026Ra Capital Management, L.P.Director,TenPercentOwnerBuy300,000$16.00$4.8M
Feb 25, 2026Cohlhepp RyanPresident and COOSell3,108$18.04$56K
Feb 25, 2026Cohlhepp RyanPresident and COOSell523$18.04$9K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance